Loading...
Ironwood Pharmaceuticals, Inc.
IRWD•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.82
$-0.00(-0.40%)
Ironwood Pharmaceuticals, Inc. (IRWD) Financial Performance & Income Statement Overview
Review Ironwood Pharmaceuticals, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-20.63%
↓ 20.63%
Operating Income Growth
109.85%
↑ 109.85%
Net Income Growth
100.09%
↑ 100.09%
Operating Cash Flow Growth
-43.55%
↓ 43.55%
Operating Margin
17.25%
↑ 17.25%
Gross Margin
99.69%
↑ 99.69%
Net Profit Margin
-9.89%
↓ 9.89%
ROE
9.91%
↑ 9.91%
ROIC
19.63%
↑ 19.63%
Ironwood Pharmaceuticals, Inc. (IRWD) Income Statement & Financial Overview
Review Ironwood Pharmaceuticals, Inc.'s (IRWD) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $90.55M | $91.59M | $94.40M | $74.88M |
| Cost of Revenue | $485000.00 | $0.00 | $506000.00 | $513000.00 |
| Gross Profit | $90.06M | $91.59M | $93.89M | $74.36M |
| Gross Profit Ratio | $0.99 | $1.00 | $0.99 | $0.99 |
| R&D Expenses | $23.93M | $29.83M | $29.88M | $25.30M |
| SG&A Expenses | $33.33M | $36.11M | $36.96M | $37.60M |
| Operating Expenses | $57.26M | $65.94M | $66.85M | $62.91M |
| Total Costs & Expenses | $57.33M | $65.96M | $67.35M | $63.42M |
| Interest Income | $778000.00 | $1.15M | $1.37M | $1.17M |
| Interest Expense | $8.91M | $9.42M | $7.47M | $6.82M |
| Depreciation & Amortization | $485000.00 | $507000.00 | $506000.00 | $513000.00 |
| EBITDA | $33.22M | $27.30M | $26.85M | $12.70M |
| EBITDA Ratio | $0.37 | $0.30 | $0.28 | $0.17 |
| Operating Income | $33.22M | $25.64M | $27.04M | $11.46M |
| Operating Income Ratio | $0.37 | $0.28 | $0.29 | $0.15 |
| Other Income/Expenses (Net) | -$8.14M | -$8.27M | -$8.17M | -$6.50M |
| Income Before Tax | $25.08M | $17.37M | $18.88M | $4.96M |
| Income Before Tax Ratio | $0.28 | $0.19 | $0.20 | $0.07 |
| Income Tax Expense | $21.89M | $13.72M | $19.74M | $9.12M |
| Net Income | $3.19M | $31.09M | -$860000.00 | -$4.16M |
| Net Income Ratio | $0.04 | $0.34 | -$0.009 | -$0.06 |
| EPS | $0.02 | $0.02 | -$0.005 | -$0.03 |
| Diluted EPS | $0.02 | $0.02 | -$0.005 | -$0.03 |
| Weighted Avg Shares Outstanding | $159.90M | $159.71M | $159.01M | $157.70M |
| Weighted Avg Shares Outstanding (Diluted) | $160.42M | $160.23M | $159.01M | $157.70M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan